Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Cantor Fitzgerald
Cipla
Julphar
McKinsey
AstraZeneca
Farmers Insurance
Colorcon

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,472,143

« Back to Dashboard

Summary for Patent: 5,472,143
Title: Atomising nozzle and filter and spray generation device
Abstract:A nozzle assembly for use in atomizing and generating sprays from a fluid. The nozzle assembly includes two members joined together. In one of the two members are formed one or more nozzle outlets, one or more fluid inlets, and a plurality of channels that form filter passageways. The nozzle outlets discharge fluid jets that impinge on one another to thereby atomize the fluid. Alternatively, an impact element or a vortex-generating structure can be used in the nozzle outlet to atomize the fluid.
Inventor(s): Bartels; Frank (Waldbronn, DE), Bachtler; Wulf (Mainz, DE), Dunne; Stephen T. (Suffolk, GB), Eicher; Joachim (Karlsruhe, DE), Freund; Bernhard (Gau-Algesheim, DE), Hart; William B. (Suffolk, GB), Lessmoellmann; Christoph (Gernsbach, DE)
Assignee: Boehringer Ingelheim International GmbH (DE) DMW (Technology) Ltd. (GB)
Application Number:08/128,021
Patent Claim Types:
see list of patent claims
Device;

Drugs Protected by US Patent 5,472,143

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,472,143

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9220505Sep 29, 1992
Germany42 36 037.4Oct 24, 1992
United Kingdom9314804Jul 19, 1993

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Moodys
Accenture
US Department of Justice
Deloitte
Julphar
Harvard Business School
Medtronic
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.